½ÃÀ庸°í¼­
»óǰÄÚµå
1362987

¼¼°èÀÇ ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ : ¼­ºñ½º À¯Çüº°, ´Ü°èº°, Ä¡·á ¿µ¿ªº°, ¿¬·É´ëº°, Áö¿ªº°, ºÎ¹®º° µ¿Çâ(2023-2030³â)

Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Area, By Age group, By Region, And Segment Forecasts, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 149 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå ¼ºÀå ¹× µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 15¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 8.07%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¦¾à ¹× ÀÇ·á ºÐ¾ßÀÇ ¼ºÀå, ÀÓ»ó½ÃÇè ¼ö¿ä Áõ°¡, ºÐ»êÇü ÀÓ»ó½ÃÇèÀÇ Ã¤ÅÃÀº ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.

±×·¯³ª Äڷγª19ÀÇ ´ëÀ¯ÇàÀº ¼¼°è ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, Äڷγª19ÀÇ ¹ß»ýÀ¸·Î ÀÎÇØ ¼¼°è ÀÓ»ó½ÃÇèÀÌ ÀÚ¹ßÀûÀ¸·Î Áߴܵǰí ÀÖ½À´Ï´Ù. ÀϽÃÀûÀÎ ºÀ¼â´Â ÀÓ»ó½ÃÇè, ƯÈ÷ ȯÀÚ ¸ðÁý »ê¾÷¿¡ Å« È¥¶õÀ» °¡Á®¿Ô½À´Ï´Ù. ºÀ¼â·Î ÀÎÇØ ȯÀÚµéÀÇ ÀÓ»ó½ÃÇè ½Ã¼³ ¹æ¹®ÀÌ Á¦ÇÑµÇ¾î °á±¹ ÀϺΠÀÓ»ó½ÃÇè¿¡¼­ ȯÀÚ Áý´ÜÀÌ ´ë°Å Å»¶ôÇÏ´Â °á°ú¸¦ ÃÊ·¡Çß½À´Ï´Ù.

±×·¯³ª ¾÷°è Àü¹ÝÀÇ ±â¾÷µéÀº M&A, ÀÓ»ó½ÃÇèÀÇ ºÐ»êÈ­, ȯÀÚ ¿ø°Ý ¸ð´ÏÅ͸µ µî µðÁöÅÐ ±â¼ú µµÀÔ°ú °°Àº Á¶Ä¡¸¦ ÅëÇØ Àü¿°º´ÀÇ ¾Ç¿µÇâÀ» ¿ÏÈ­ÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεé·Î ÀÎÇØ 2021³â ÀÌÈÄ ¾÷°è´Â Á¤»óÀûÀÎ ¼ºÀå·ü·Î µ¹¾Æ°¥ ¼ö ÀÖ¾ú½À´Ï´Ù.

Á¦¾àȸ»çµéÀº ÇコÄɾî Àü¹® Áö½ÄÀÇ ¼¼°è¿¡¼­ °æÀï·Â°ú À¯¿¬¼ºÀ» À¯ÁöÇϱâ À§ÇØ Á¡Â÷ ¿¬±¸°³¹ß Ȱµ¿¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ±âÃÊ ¿¬±¸ºÎÅÍ È¯ÀÚ µî·Ï ¼­ºñ½º±îÁö ´Ù¾çÇÑ ¾÷¹«ÀÇ ¾Æ¿ô¼Ò½Ì¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. µðÁöÅÐ Ä¿¹Â´ÏÄÉÀ̼ÇÀº ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå Àüü¿¡¼­ º¼ ¼ö ÀÖ´Â ÃÖ±Ù Æ®·»µå Áß ÇϳªÀÔ´Ï´Ù.

¿Â¶óÀÎ Ç÷§ÆûÀÇ µµ¿òÀ¸·Î ä¿ëÀÌ ÇÕ¸®ÀûÀ¸·Î ¼ºÀåÇϰí ÀÖ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀüÅëÀûÀÎ Àμ⹰À̳ª TV, ¶óµð¿À¸¦ ÅëÇÑ È«º¸¿¡ ºñÇØ ´ë´Ù¼öÀÇ »ç¶÷µéÀÌ ¿Â¶óÀÎ ¼Ò½º¸¦ ÅëÇØ ÀÓ»ó½ÃÇè¿¡ ´ëÇØ ¾Ë°Ô µË´Ï´Ù. ÀÌ¿¡ µû¶ó ¼Ò¼È ¹Ìµð¾î, À¥ ûÃë, ¿Â¶óÀÎ ½ºÅ©¸®´× µî ¿©·¯ °¡Áö e-¸®Å©·çÆÃ Àü¼úÀÌ ¹ßÀüÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¸ð¹ÙÀÏ ±â±âÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½º¸¶Æ®Æù ¿ëµµ°ú ¹®ÀÚ ¸Þ½ÃÁöÀÇ »ç¿ëµµ È®»êµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ºÏ¹Ì¿¡¼­´Â ÀÓ»ó ¿¬±¸ÀÇ ¾à 11%°¡ ¼Ò¼È ¹Ìµð¾î Ä¿¹Â´ÏÄÉÀ̼ǰú °ü·ÃµÇ¾î ÀÖ½À´Ï´Ù. µû¶ó¼­ ¾Õ¼­ ¾ð±ÞÇÑ ¿äÀεéÀº ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • 3»ó ½ÃÇèÀº ºñ¿ëÀÌ ºñ½Î±â ¶§¹®¿¡ 2022³â 3»ó ½ÃÇèÀÌ 57.2% ÀÌ»óÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ȯÀÚ ¸ðÁý ¹× µî·Ï ¼­ºñ½º ºÐ¾ß´Â ȯÀÚ µî·Ï ¼­ºñ½º¿¡¼­ µðÁöÅÐ ±â¼ú äÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È 8.3%ÀÇ ³ôÀº ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • Ä¡·á ºÐ¾ßº°·Î´Â ÅëÁõ ¹× ¸¶Ãë°¡ 2021³â 13.7%·Î °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â ÅëÁõ °ü¸®¿Í °ü·ÃµÈ ºñ¿ëÀÌ ´Ù¸¥ Ä¡·á ºÐ¾ßº¸´Ù ÈξÀ ³ô±â ¶§¹®¿¡ ȯÀÚ ¸ðÁý ¹× À¯Áö ¼­ºñ½º ºñ¿ëÀÌ µ¿½Ã¿¡ Áõ°¡Çϱ⠶§¹®ÀÔ´Ï´Ù.
  • ¿¬·É´ëº°·Î´Â ¼ºÀÎ(18-64¼¼) ºÎ¹®ÀÌ ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â ÀÌ ¿¬·É´ëÀÇ °Ç°­ »óÅ À¯º´·ü Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.
  • ºÏ¹Ì´Â 2022³â 50.1%·Î °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â ¸¹Àº ÀÓ»ó½ÃÇèÀÌ ÁøÇà ÁßÀ̱⠶§¹®¿¡ ÀÌ ½ÃÀåÀº Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå : º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
  • ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ¿ªÇÐ
  • ½ÃÀå ¿ªÇÐ
  • ȯÀÚ Ã¤Åà °ü¸® µ¿Çâ
  • PorterÀÇ Five Forces ºÐ¼®
  • PEST ºÐ¼®
  • COVID-19¿¡ ÀÇÇÑ ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦4Àå ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå : ¼­ºñ½º À¯Çü ºÎ¹® ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¼­ºñ½º À¯Çü ºÎ¹®º° ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå : Áß¿ä Æ÷ÀÎÆ®
  • ¼­ºñ½º À¯Çüº°
  • Á¤ÀÇ¿Í ¹üÀ§
  • ¼­ºñ½ºº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â

Á¦5Àå ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå : ´Ü°è ºÎ¹® ÃßÁ¤¡¤µ¿Ç⠺м®

  • ´Ü°è ºÎ¹®º° ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå : Áß¿ä Æ÷ÀÎÆ®
  • ´Ü°èº°
  • Á¤ÀÇ¿Í ¹üÀ§
  • ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ´Ü°è : ´Ü°è ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â

Á¦6Àå ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå : Ä¡·á ¿µ¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Ä¡·á ¿µ¿ª ºÎ¹®º° ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå : Áß¿ä Æ÷ÀÎÆ®
  • Ä¡·á ¿µ¿ªº°
  • Á¤ÀÇ¿Í ¹üÀ§
  • ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º : ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â

Á¦7Àå ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå : ¿¬·ÉÃþ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º ½ÃÀå ¿¬·ÉÃþº° ºÎ¹® : Áß¿ä Æ÷ÀÎÆ®
  • ¿¬·ÉÃþº°
  • Á¤ÀÇ¿Í ¹üÀ§
  • ÀÓ»ó½ÃÇè ȯÀÚ ¸ðÁý ¼­ºñ½º : ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â

Á¦8Àå Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®, 2018-2030³â

  • Áö¿ªº° Àü¸Á
  • Áö¿ª ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • Áö¿ª ¸¶ÄÏ Ç÷¹À̽º, Áß¿ä Æ÷ÀÎÆ®
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • ű¹
    • È£ÁÖ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ ºÐ·ù
  • ½ÃÀå ÁøÃâ±â¾÷ ¼³¸í
  • À繫 ½ÇÀû
  • ¼­ºñ½º º¥Ä¡¸¶Å·
    • ¸¶ÄÏ ¸®´õ
  • Àü·« ¸ÅÇÎ
    • ¼­ºñ½º °³½Ã/¾÷±×·¹À̵å
    • ÇÕº´/Àμö/ÇÕº´»ç¾÷
    • ÆÄÆ®³Ê½Ê °è¾à
    • È®´ë
    • ±âŸ

Á¦10Àå Áß¿ä Æ÷ÀÎÆ®

LSH 23.10.27

Clinical Trial Patient Recruitment Services Market Growth & Trends:

The global clinical trial patient recruitment services market size is expected to reach USD 1.56 billion by 2030 witnessing a CAGR of 8.07% from 2023 to 2030, according to a new report by Grand View Research, Inc..

The growing pharmaceutical and medical sectors, increasing demand for clinical studies, and adoption of decentralized clinical trials are a few of the factors supporting the growth of the clinical trial patient recruitment services market.

However, the COVID-19 pandemic has affected the global market, the outbreak of COVID-19 has caused a voluntary pause in the clinical trials across the globe. The temporary lockdown has significantly disrupted clinical trials, especially in the patient recruitment industry. The lockdown has restricted the patient's visits to trial sites, which has ultimately led to significant dropouts of the patient population from several clinical trials.

However, companies operating across the industry have focused on mitigating the negative impact of the pandemic by adopting measures such as mergers and acquisitions, implementation of digital technologies such as decentralized clinical trials, remote monitoring of patients, and a few others. Such factors helped the industry to flourish back to its normal growth rate post-2021.

Pharmaceutical organizations are progressively focusing on R&D activities to remain competitive & flexible in the world of healthcare expertise. Companies are focusing on outsourcing tasks ranging from basic research to patient enrollment services. Digital methods of communication are one of the most recent trends witnessed across the patient recruitment services market.

With the help of online platforms, the recruitment growth seems to be streamlining. The majority of people learn about clinical trials through online sources compared to traditional print or TV/radio outreach. Hence, several e-recruitment tactics are evolving, such as social media, web listening, as well as online screeners.

In addition, with the increasing usage of mobile devices, the use of smartphone applications and text messaging has become more widespread. For instance, in North America, about 11% of clinical studies involve social media communications. Hence, the aforementioned factors are anticipated to support the growth of the market.

Clinical Trial Patient Recruitment Services Market Report Highlights:

  • The phase III segment dominated the market with a revenue share of more than 57.2% in 2022 due to the high cost associated with phase III studies
  • The patient recruitment & registry services segment is anticipated to witness lucrative growth of 8.3% during the forecast period owing to the increasing adoption of digital technologies in patient enrolment services
  • Pain and Anesthesia in terms of therapeutic areas held the highest market share of 13.7% in 2021. This is because the cost related to pain management is significantly higher than in other therapeutic areas, thus simultaneously increasing the fees for patient recruitment and retention services
  • In terms of age group, the adult (18 - 64 Years) segment is expected to witness a considerable growth rate across the forecast timeframe, owing to the increasing prevalence of health conditions in the age group
  • North America held the largest share of 50.1% in 2022. The market is expected to grow significantly, driven by the region's substantial number of ongoing clinical trials.

Table Of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Report Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Primary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1:
    • 1.10.2 Objective - 2:
    • 1.10.3 Objective - 3:
    • 1.10.4 Objective - 4:

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot
  • 2.4 Segment Outlook

Chapter 3 Clinical Trial Patient Recruitment Services Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Clinical Trial Patient Recruitment Services Dynamics
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 High R&D Spending Of Pharmaceutical Companies
      • 3.3.1.2 Increase In Number Of Global Clinical Trials
      • 3.3.1.3 Adoption Of Digital Clinical Trials
      • 3.3.1.4 Increase In Offshoring Of Clinical Trials In Emerging Market
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Lack Of Awareness Towards Clinical Trials
  • 3.4 Patient Recruitment Management Trends
    • 3.3.1 Patient Recruitment Tactics
  • 3.5 Porter's Five Forces Analysis
  • 3.6 Pest Analysis
  • 3.7 Covid-19 Impact On Clinical Trial Patient Recruitment Services Market
    • 3.7.1 Disrupted Clinical Trials:
    • 3.7.2 Obstacles In Clinical Trials:
    • 3.7.3 Covid-19 Impact On Key Market Players
      • 3.7.3.1 IQVIA
      • 3.7.3.2 ICON PLC
      • 3.7.3.3 PPD (Thermo Fisher Scientific Inc.)
      • 3.7.3.4 CHARLES RIVER Laboratories
    • 3.7.4 Post-Covid-19 Impact On The Market

Chapter 4 Clinical Trial Patient Recruitment Services Market: Service Type Segment Estimates & Trend Analysis

  • 4.1 Clinical Trial Patient Recruitment Services Market By Service Type Segment: Key Takeaways
  • 4.2 Clinical Trial Patient Recruitment Services Market Estimates & Forecast, By Service Type (USD Million)
  • 4.3 Definitions & Scope
  • 4.4 By Services Market Share Analysis, 2022 & 2030
    • 4.4.1 Patient Recruitment & Registry Services
      • 4.4.1.1 Patient Recruitment & Registry Services Market, 2018 - 2030 (USD Million)
    • 4.4.2 Patient Retention Market, 2018 - 2030 (USD Million)
      • 4.4.2.1 Patient Retention Market, 2018 - 2030 (USD Million)
    • 4.4.3 Others
      • 4.4.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Clinical Trial Patient Recruitment Services Market: Phase Segment Estimates & Trend Analysis

  • 5.1 Clinical Trial Patient Recruitment Services Market By Phase Segment: Key Takeaways
  • 5.2 Clinical Trial Patient Recruitment Services Market Estimates & Forecast, By Phase (USD Million)
  • 5.3 Clinical Trial Patient Recruitment Services Market: Definition & Scope
  • 5.4 Clinical Trial Patient Recruitment Phase: Phase Market Share Analysis, 2022 & 2030
    • 5.4.1 Phase I
      • 5.4.1.1 Phase I Market, 2018 - 2030 (USD Million)
    • 5.4.2 Phase Ii
      • 5.4.2.1 Phase Ii Market, 2018 - 2030 (USD Million)
    • 5.4.3 Phase Iii
      • 5.4.3.1 Phase Iii Market, 2018 - 2030 (USD Million)
    • 5.4.4 Phase Iv
      • 5.4.4.1 Phase Iv Market, 2018 - 2030 (USD Million)

Chapter 6 Clinical Trial Patient Recruitment Services Market: Therapeutic Areas Segment Estimates & Trend Analysis

  • 6.1 Clinical Trial Patient Recruitment Services Market By Therapeutic Areas Segment: Key Takeaways
  • 6.2 Clinical Trial Patient Recruitment Services Market Estimates & Forecast, By Therapeutic Areas (USD Million)
  • 6.3 Definitions & Scope
  • 6.4 Clinical Trial Patient Recruitment Services: Market Share Analysis, 2022 & 2030
    • 6.4.1 Pain And Anesthesia
      • 6.4.1.1 Pain And Anesthesia Market, 2018 - 2030 (USD Million)
    • 6.4.2 Oncology
      • 6.4.2.1 Oncology Market, 2018 - 2030 (USD Million)
    • 6.4.3 Central Nervous System
      • 6.4.3.1 Central Nervous System Market, 2018 - 2030 (USD Million)
    • 6.4.4 Cardiovascular
      • 6.4.4.1 Cardiovascular Market, 2018 - 2030 (USD Million)
    • 6.4.5 Respiratory
      • 6.4.5.1 Respiratory Market, 2018 - 2030 (USD Million)
    • 6.4.6 Endocrine
      • 6.4.6.1 Endocrine Market, 2018 - 2030 (USD Million)
    • 6.4.7 Anti-Infective
      • 6.4.7.1 Anti-Infective Market, 2018 - 2030 (USD Million)
    • 6.4.8 Others
      • 6.4.8.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Clinical Trial Patient Recruitment Services Market: Age Group Segment Estimates & Trend Analysis

  • 7.1 Clinical Trial Patient Recruitment Services Market By Age Group Segment: Key Takeaways
  • 7.2 Clinical Trial Patient Recruitment Services Market Estimates & Forecast, By Age Group (USD Million)
  • 7.3 Definitions & Scope
  • 7.4 Clinical Trial Patient Recruitment: Market Share Analysis, 2022 & 2030
    • 7.4.1 Child
      • 7.4.1.1 Child Market, 2018 - 2030 (USD Million)
    • 7.4.2 Adults
      • 7.4.2.1 Adults Market, 2018 - 2030 (USD Million)
    • 7.4.3 Older Adults
      • 7.4.3.1 Older Adults Market, 2018 - 2030 (USD Million)

Chapter 8 Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 8.1 Regional Outlook
  • 8.2 Regional Market Share Analysis, 2022 & 2030
  • 8.3 Regional Marketplace, Key Takeaways
  • 8.4 Regional Marketplace, Key Takeaways
  • 8.5 North America
    • 8.5.1 Regulatory Framework:
    • 8.5.2 North America Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3 U.S.
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 U.S. Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.3.3 Competitive And Market Scenario
    • 8.5.4 Canada
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Canada Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.4.3 Competitive And Market Scenario
  • 8.6 Europe
    • 8.6.1 Regulatory Framework:
      • 8.6.1.1 Europe Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2 Germany
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 Germany Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.2.3 Competitive And Market Scenario
    • 8.6.3 UK
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 UK Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.3.3 Competitive And Market Scenario
    • 8.6.4 France
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 France Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.4.3 Competitive And Market Scenario
    • 8.6.5 Spain
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Spain Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.5.3 Competitive And Market Scenario
    • 8.6.6 Italy
      • 8.6.6.1 Key Country Dynamics
      • 8.6.6.2 Italy Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.6.3 Competitive And Market Scenario
    • 8.6.7 Denmark
      • 8.6.7.1 Key Country Dynamics
      • 8.6.7.2 Denmark Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.7.3 Competitive And Market Scenario
    • 8.6.8 Sweden
      • 8.6.8.1 Key Country Dynamics
      • 8.6.8.2 Sweden Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.8.3 Competitive And Market Scenario
    • 8.6.9 Norway
      • 8.6.9.1 Key Country Dynamics
      • 8.6.9.2 Norway Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.9.3 Competitive And Market Scenario
  • 8.7 Asia Pacific
    • 8.7.1 Regulatory Framework:
      • 8.7.1.1 Asia Pacific Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2 Japan
      • 8.7.2.1 Key Country Dynamics
      • 8.7.2.2 Japan Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.2.3 Competitive And Market Scenario
    • 8.7.3 China
      • 8.7.3.1 Key Country Dynamics
      • 8.7.3.2 China Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.3.3 Competitive And Market Scenario
    • 8.7.4 India
      • 8.7.4.1 Key Country Dynamics
      • 8.7.4.2 India Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.4.3 Competitive And Market Scenario
    • 8.7.5 South Korea
      • 8.7.5.1 Key Country Dynamics
      • 8.7.5.2 South Korea Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.5.3 Competitive And Market Scenario
    • 8.7.6 Thailand
      • 8.7.6.1 Key Country Dynamics
      • 8.7.6.2 Thailand Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.6.3 Competitive And Market Scenario
    • 8.7.7 Australia
      • 8.7.7.1 Key Country Dynamics
      • 8.7.7.2 Australia Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.7.3 Competitive And Market Scenario
  • 8.8 Latin America
    • 8.8.1 Regulatory Framework:
    • 8.8.2 Latin America Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3 Brazil
      • 8.8.3.1 Key Country Dynamics
      • 8.8.3.2 Brazil Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.8.3.3 Competitive And Market Scenario
    • 8.8.4 Mexico
      • 8.8.4.1 Key Country Dynamics
      • 8.8.4.2 Mexico Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.8.4.3 Competitive And Market Scenario
    • 8.8.5 Argentina
      • 8.8.5.1 Key Country Dynamics
      • 8.8.5.2 Argentina Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.8.5.3 Competitive And Market Scenario
  • 8.9 MEA
    • 8.9.1 Regulatory Framework:
    • 8.9.2 MEA Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.9.3 South Africa
      • 8.9.2.1 Key Country Dynamics
      • 8.9.2.2 South Africa Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.9.2.3 Competitive And Market Scenario
    • 8.9.4 Saudi Arabia
      • 8.9.3.1 Key Country Dynamics
      • 8.9.3.2 Saudi Arabia Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.9.3.3 Competitive And Market Scenario
    • 8.9.5 UAE
      • 8.9.4.1 Key Country Dynamics
      • 8.9.4.2 UAE Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.9.4.3 Competitive And Market Scenario
    • 8.9.5 Kuwait
      • 8.9.5.1 Key Country Dynamics
      • 8.9.5.2 Kuwait Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.9.5.3 Competitive And Market Scenario

Chapter 9 Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Participants Overview
  • 9.3 Financial Performance
  • 9.4 Service Benchmarking
    • 9.4.1 Market Leaders
      • 9.4.1.1 Clinical Trial Patient Recruitment Services Market Share Analysis, 2022
  • 9.5 Strategy Mapping
    • 9.5.1 Service Launches/Upgrades
    • 9.5.2 Mergers/Acquisitions/Joint Ventures
    • 9.5.3 Partnership/ Agreement
    • 9.5.4 Expansion
    • 9.5.5 Others

Chapter 10 Key Takeaways

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦